Stay updated on Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.

Latest updates to the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s displayed site revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or release change rather than an update to the clinical trial record content.SummaryDifference0.1%

- Check26 days agoChange DetectedFooter revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 was added. Notices about government funding and the prior revision (v3.4.1) were removed.SummaryDifference0.4%

- Check98 days agoChange DetectedA government funding lapse notice with operating status guidance was added, and the page now shows a revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.